Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Neurology

The Science of BPAN: Recycling and Iron Control

At a Glance

BPAN results from pathogenic WDR45 variants that disrupt autophagy, the cell’s recycling system. This can cause waste buildup in nerve cells and iron accumulation in parts of the brain, but MRI brain iron does not indicate a blood iron disorder or determine symptoms by itself.

To understand Beta-propeller Protein-Associated Neurodegeneration (BPAN), it helps to look at the smallest building blocks of the body: the cells. In BPAN, the central issue is a breakdown in how cells recycle their parts and manage their internal materials. This process is controlled by a single gene called WDR45.

The Cell’s Recycling System: Autophagy

Every cell in your body has a “trash and recycling” system called autophagy. This system identifies old or damaged parts of the cell, wraps them in a specialized container (an autophagosome), and delivers them to a recycling center (the lysosome) to be broken down and reused [1][2].

The WDR45 gene provides the instructions for making a protein called WIPI4. Think of WIPI4 as a foreman at a construction site who helps build the recycling containers [3]. When the WDR45 gene has a pathogenic variant, the WIPI4 protein cannot do its job properly. As a result:

  • The recycling containers are built too small or are not built at all [2].
  • The cell’s “trash” (damaged proteins and old structures) begins to pile up, especially in the long arms of nerve cells (axons) [4][5].
  • Over time, this accumulation of waste makes it hard for the nerve cells to function and can eventually cause them to stop working [6].

A Proposed Mechanism: Ferritinophagy and Brain Iron

Iron is essential for the brain, but it must be handled carefully. Usually, the body stores iron safely inside a protein called ferritin. When the cell needs that iron, it uses the recycling system (autophagy) to break down the ferritin and release the iron. This specific proposed process is called ferritinophagy [7].

In BPAN, a current research model suggests that because the recycling system is broken, the cell cannot properly break down ferritin [8]. This leads to a strange paradox:

  1. Too much storage: Iron gets “stuck” inside ferritin “containers” that the cell can’t open [7].
  2. Not enough usable iron: Even though the cell is full of iron, it cannot use it for its daily needs [8][7].

This “stuck” iron builds up in specific areas of the brain, most notably the substantia nigra and the globus pallidus [9].

Important Warning: The precise link between this biology and the physical symptoms of BPAN remains incompletely understood. The brain iron seen on an MRI is completely separate from routine blood iron measurements. Do not assume that you have systemic iron deficiency or overload. Do not start iron supplements, “mitochondrial” supplements, antioxidants, or iron chelators based on this biological metaphor, unless a clinician identifies a completely separate reason to do so.

The X-Linked Inheritance Pattern

BPAN is caused by variants on the X chromosome. Because females have two X chromosomes (XX) and males have only one (XY), the condition affects the sexes differently:

  • X-Linked Dominant: A variant in just one of the two X chromosomes is enough to cause the condition in females [10].
  • Female Predominance: Because the WDR45 gene is so vital, severe variants are often lethal to males before birth. This is why most people diagnosed with BPAN are female. However, affected males who survive do exist; they may have hypomorphic variants or carry the variant in only some of their cells (a condition called mosaicism) [11][12].
  • Variability: Females with BPAN can have very different symptoms. This is partially due to X-inactivation, a natural process where each cell “turns off” one of its two X chromosomes. However, X-inactivation is not a reliable individual prognostic test to predict severity [13][14].
  • De Novo Variants: Most WDR45 variants are “de novo” (spontaneous). While this usually lowers recurrence risk for parents, the risk is not zero due to possible parental germline mosaicism. If a mother carries the pathogenic variant, she has a 50% chance of transmitting it in each pregnancy [11].

While the biology of BPAN is complex, researchers are using this knowledge to look for new ways to support cell health and manage symptoms in the future [15][16].

Common questions in this guide

What does the WDR45 gene do in BPAN?
The WDR45 gene provides instructions for WIPI4, a protein that helps cells build containers for autophagy, their recycling system. A pathogenic WDR45 variant can disrupt this process, allowing damaged proteins and other cellular waste to build up in nerve cells.
Why can iron build up in the brain with BPAN?
A current research model suggests that disrupted autophagy prevents cells from properly recycling ferritin, the protein that stores iron. Iron may then become trapped in storage and accumulate in brain regions such as the substantia nigra and globus pallidus, but the exact connection to symptoms is not fully understood.
Does brain iron on an MRI mean I have low or high blood iron?
No. Iron seen in specific brain regions on an MRI is separate from routine blood iron measurements and does not by itself show that the body has iron deficiency or iron overload. Do not take iron, antioxidant, mitochondrial, or iron-chelating supplements for BPAN unless a clinician identifies a separate medical reason.
How is BPAN inherited?
BPAN follows an X-linked inheritance pattern, and most WDR45 variants occur spontaneously rather than being inherited. If a mother carries a pathogenic WDR45 variant, she has a 50% chance of passing it on in each pregnancy, while parental germline mosaicism can make recurrence risk possible even when testing is negative in blood.
Can X-inactivation predict how severe BPAN will be?
X-inactivation may help explain why females with BPAN can have different symptoms because cells naturally switch off one X chromosome. However, an X-inactivation result is not a reliable way to predict an individual person’s future severity.
Should relatives be tested for a WDR45 variant?
A genetic counselor or clinician can review the specific WDR45 result and determine which relatives may benefit from testing. Family evaluation can help identify an affected parent, clarify reproductive risks, and account for possibilities such as mosaicism.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific type of WDR45 variant is present, and what is its expected impact on the protein's function?
  2. 2.Since this condition is X-linked, should I or other family members be tested for the WDR45 variant?
  3. 3.Does the genetic report suggest the variant is present in all cells, or is there a possibility of 'mosaicism'?
  4. 4.Are there any specific therapies or clinical trials focusing on the autophagy pathway in BPAN?
  5. 5.How does 'X-inactivation' explain why some females with BPAN have more severe symptoms than others?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    WIPI3 and WIPI4 β-propellers are scaffolds for LKB1-AMPK-TSC signalling circuits in the control of autophagy.

    Bakula D, Müller AJ, Zuleger T, et al.

    Nature communications 2017; (8()):15637 doi:10.1038/ncomms15637.

    PMID: 28561066
  2. 2

    β-propeller proteins WDR45 and WDR45B regulate autophagosome maturation into autolysosomes in neural cells.

    Ji C, Zhao H, Chen D, et al.

    Current biology : CB 2021; (31(8)):1666-1677.e6 doi:10.1016/j.cub.2021.01.081.

    PMID: 33636118
  3. 3

    Beta-propeller protein-associated neurodegeneration (BPAN) as a genetically simple model of multifaceted neuropathology resulting from defects in autophagy.

    Hor CHH, Tang BL

    Reviews in the neurosciences 2019; (30(3)):261-277.

    PMID: 30204590
  4. 4

    The autophagy gene Wdr45/Wipi4 regulates learning and memory function and axonal homeostasis.

    Zhao YG, Sun L, Miao G, et al.

    Autophagy 2015; (11(6)):881-90 doi:10.1080/15548627.2015.1047127.

    PMID: 26000824
  5. 5

    WDR45 contributes to neurodegeneration through regulation of ER homeostasis and neuronal death.

    Wan H, Wang Q, Chen X, et al.

    Autophagy 2020; (16(3)):531-547 doi:10.1080/15548627.2019.1630224.

    PMID: 31204559
  6. 6

    Pathological characteristics of axons and proteome patterns in midbrain dopaminergic neurodegeneration induced by WDR45-deficiency.

    Le W, Wang P, Al-Nusaif M, et al.

    Research square 2023; doi:10.21203/rs.3.rs-2901370/v1.

    PMID: 37292937
  7. 7

    WDR45 variants cause ferrous iron loss due to impaired ferritinophagy associated with nuclear receptor coactivator 4 and WD repeat domain phosphoinositide interacting protein 4 reduction.

    Tsukida K, Muramatsu SI, Osaka H, et al.

    Brain communications 2022; (4(6)):fcac304 doi:10.1093/braincomms/fcac304.

    PMID: 36751498
  8. 8

    Mutant WDR45 Leads to Altered Ferritinophagy and Ferroptosis in β-Propeller Protein-Associated Neurodegeneration.

    Diaw SH, Ganos C, Zittel S, et al.

    International journal of molecular sciences 2022; (23(17)) doi:10.3390/ijms23179524.

    PMID: 36076926
  9. 9

    Phenotypic and Imaging Spectrum Associated With WDR45.

    Adang LA, Pizzino A, Malhotra A, et al.

    Pediatric neurology 2020; (109()):56-62 doi:10.1016/j.pediatrneurol.2020.03.005.

    PMID: 32387008
  10. 10

    Consensus clinical management guideline for beta-propeller protein-associated neurodegeneration.

    Wilson JL, Gregory A, Kurian MA, et al.

    Developmental medicine and child neurology 2021; (63(12)):1402-1409 doi:10.1111/dmcn.14980.

    PMID: 34347296
  11. 11

    Lessons from a pair of siblings with BPAN.

    Zarate YA, Jones JR, Jones MA, et al.

    European journal of human genetics : EJHG 2016; (24(7)):1080-3 doi:10.1038/ejhg.2015.242.

    PMID: 26577041
  12. 12

    De novo variants in WDR45 underlie beta-propeller protein-associated neurodegeneration in five independent families.

    Tang X, Lan X, Song X, et al.

    Molecular genetics & genomic medicine 2020; (8(11)):e1499 doi:10.1002/mgg3.1499.

    PMID: 33037762
  13. 13

    Childhood Dystonia-Parkinsonism Following Infantile Spasms-Clinical Clue to Diagnosis in Early Beta-Propeller Protein-Associated Neurodegeneration.

    Hornemann F, Le Duc D, Roth C, et al.

    Neuropediatrics 2020; (51(1)):22-29 doi:10.1055/s-0039-1696688.

    PMID: 31505688
  14. 14

    A Case of Beta-Propeller Protein-Associated Neurodegeneration With a Unique Truncating Variant in the WDR45 Gene and Uncommon Clinical and Radiologic Findings.

    Esbit S, Sidlow R

    Cureus 2024; (16(4)):e58127 doi:10.7759/cureus.58127.

    PMID: 38741870
  15. 15

    L-serine restored lysosomal failure in cells derived from patients with BPAN reducing iron accumulation with eliminating lipofuscin.

    Lee HE, Jung M, Choi K, et al.

    Free radical biology & medicine 2024; (221()):273-282 doi:10.1016/j.freeradbiomed.2024.05.017.

    PMID: 38740102
  16. 16

    Antioxidants Prevent Iron Accumulation and Lipid Peroxidation, but Do Not Correct Autophagy Dysfunction or Mitochondrial Bioenergetics in Cellular Models of BPAN.

    Suárez-Carrillo A, Álvarez-Córdoba M, Romero-González A, et al.

    International journal of molecular sciences 2023; (24(19)) doi:10.3390/ijms241914576.

    PMID: 37834028

This page explains BPAN biology, WDR45 inheritance, and brain iron for informational purposes only and does not constitute medical advice. Discuss genetic testing, MRI findings, supplements, and treatment decisions with your clinician.

Get notified when new evidence is published on Beta-propeller protein-associated neurodegeneration.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.